Nerve growth factor precursor alterations in neuron‐derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Natalia Valle-Tamayo und 22 weiteren Autor:innen. Beteiligte Einrichtung: Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau- Universitat Autònoma de Barcelona, Barcelona, Sp…. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Extracellular Vesicles, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Instituto de Salud Carlos III (Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España), NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND In Down syndrome (DS) and Alzheimer's disease (AD), nerve growth factor precursor protein (proNGF) accumulates in the brain. However, its non‐invasive detection using neuron‐derived extracellular vesicles (NDEVs) from plasma remains unexplored. METHODS We included 139 adults with DS (45 asymptomatic [aDS], 94 symptomatic for AD [sDS]) and 37 healthy controls. NDEVs were isolated from plasma. ProNGF and tetraspanin (CD81) were quantified by enzyme‐linked immunosorbent assay. We assessed proNGF/CD81 changes with age, along the AD continuum (aDS and sDS), and associations with cerebrospinal fluid (CSF), plasma biomarkers, episodic memory, and basal forebrain volume. RESULTS In DS, proNGF/CD81 levels increased with age and were higher in NDEVs from asymptomatic and symptomatic individuals compared to controls, with the highest levels in the symptomatic group. ProNGF correlated with CSF phosphorylated tau (p‐tau)181, plasma p‐tau217, neurofilament light chain, and episodic memory. DISCUSSION ProNGF/CD81 levels in NDEVs increase along the AD continuum in DS and parallel tau pathology, indicating the potential as a promising biomarker for monitoring disease progression in plasma. Highlights Nerve growth factor precursor protein (ProNGF)/tetraspanin (CD81) ratio increased in the third decade of life, 20 years before Alzheimer's disease (AD) symptom onset in Down syndrome (DS). proNGF/CD81 concentrations were significantly higher in individuals with DS compared to controls and were notably elevated in individuals with DS and symptomatic AD compared to asymptomatic AD. proNGF/CD81 concentrations were associated with tau pathology and neuronal injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau- Universitat Autònoma de Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- Neuroradiology Section, Department of Radiology - Memory Unit, Department of Neurology, Institut de Recerca Sant Pau. Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) and Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Alicante, Spain.
- Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Förderung
- NIH HHS
- Instituto de Salud Carlos III (Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España)
- NIA NIH HHS
- Horizon Europe - Research and Innovation Funding Programme
- Department de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca I Innovació en Salut
- Jerome Lejeune Foundation (France)
- Alzheimer's Association
- Fundación Tatiana Pérez de Guzmán el Bueno
Zitieren
APA
Valle-Tamayo, N., Aranha, M. R., Pérez-González, R., Serrano-Requena, S., Videla, L., Barroeta, I., Benejam, B., Chiva-Blanch, G., Jimenez, A., Busciglio, J., Wisniewski, T., Do Carmo, S., Álvarez-Sánchez, E., Muñoz, L., Bejanin, A., Belbin, O., Alcolea, D., Carmona-Iragui, M., Lleó, A., …, & Iulita, M. F. (2025). Nerve growth factor precursor alterations in neuron‐derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70137
Vancouver
Valle-Tamayo N, Aranha MR, Pérez-González R, Serrano-Requena S, Videla L, Barroeta I, et al. Nerve growth factor precursor alterations in neuron‐derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70137
BibTeX
@article{ValleTamayo2025,
author = {Valle-Tamayo, Natalia and Aranha, Mateus Rozalem and Pérez-González, Rocío and Serrano-Requena, Sara and Videla, Laura and Barroeta, Isabel and Benejam, Bessy and Chiva-Blanch, Gemma and Jimenez, Amanda and Busciglio, Jorge and Wisniewski, Thomas and Do Carmo, Sonia and Álvarez-Sánchez, Esther and Muñoz, Laia and Bejanin, Alexandre and Belbin, Olivia and Alcolea, Daniel and Carmona-Iragui, María and Lleó, Alberto and Cuello, A Claudio and Fortea, Juan and Dols-Icardo, Oriol and Iulita, M Florencia},
title = {Nerve growth factor precursor alterations in neuron‐derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70137}
}
EUVIMED